A case of ticlopidine induced acute cholestatic hepatitis and pure red cell aplasia
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, J.Y. | - |
dc.contributor.author | Park, E.B. | - |
dc.contributor.author | Ahn, J.H. | - |
dc.contributor.author | Suh, S.J. | - |
dc.contributor.author | Jung, Y.K. | - |
dc.contributor.author | Kim, J.H. | - |
dc.contributor.author | Shin, B.K. | - |
dc.contributor.author | Yang, J.H. | - |
dc.contributor.author | Yeon, J.E. | - |
dc.contributor.author | Byun, K.S. | - |
dc.date.accessioned | 2021-09-09T15:52:03Z | - |
dc.date.available | 2021-09-09T15:52:03Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2008 | - |
dc.identifier.issn | 1738-222X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/125329 | - |
dc.description.abstract | Ticlopidine inhibits platelet aggregation and provides beneficial secondary prevention of cerebrovascular and coronary artery disease. Frequently reported adverse effects of ticlopidine include diarrhea, nausea, and rash. However, to our knowledge, there are only a few published reports of the simultaneous occurrence of cholestatic hepatitis and pure red cell aplasia. Here we report a patient with simultaneous severe cholestatic hepatitis and pure red cell aplasia associated with ticlopidine. Although these adverse effects are rare, periodic hematological and liver function tests are recommended after starting ticlopidine. | - |
dc.language | Korean | - |
dc.language.iso | ko | - |
dc.subject | antithrombocytic agent | - |
dc.subject | ticlopidine | - |
dc.subject | acute disease | - |
dc.subject | article | - |
dc.subject | case report | - |
dc.subject | chemically induced disorder | - |
dc.subject | cholestasis | - |
dc.subject | female | - |
dc.subject | human | - |
dc.subject | liver function test | - |
dc.subject | middle aged | - |
dc.subject | pathology | - |
dc.subject | pure red cell anemia | - |
dc.subject | toxic hepatitis | - |
dc.subject | Acute Disease | - |
dc.subject | Cholestasis | - |
dc.subject | Female | - |
dc.subject | Hepatitis, Toxic | - |
dc.subject | Humans | - |
dc.subject | Liver Function Tests | - |
dc.subject | Middle Aged | - |
dc.subject | Platelet Aggregation Inhibitors | - |
dc.subject | Red-Cell Aplasia, Pure | - |
dc.subject | Ticlopidine | - |
dc.title | A case of ticlopidine induced acute cholestatic hepatitis and pure red cell aplasia | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, J.H. | - |
dc.contributor.affiliatedAuthor | Shin, B.K. | - |
dc.contributor.affiliatedAuthor | Yeon, J.E. | - |
dc.identifier.doi | 10.3350/kjhep.2008.14.1.102 | - |
dc.identifier.scopusid | 2-s2.0-58149139980 | - |
dc.identifier.bibliographicCitation | The Korean journal of hepatology, v.14, no.1, pp.102 - 107 | - |
dc.relation.isPartOf | The Korean journal of hepatology | - |
dc.citation.title | The Korean journal of hepatology | - |
dc.citation.volume | 14 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 102 | - |
dc.citation.endPage | 107 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001242486 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | antithrombocytic agent | - |
dc.subject.keywordPlus | ticlopidine | - |
dc.subject.keywordPlus | acute disease | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | case report | - |
dc.subject.keywordPlus | chemically induced disorder | - |
dc.subject.keywordPlus | cholestasis | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | liver function test | - |
dc.subject.keywordPlus | middle aged | - |
dc.subject.keywordPlus | pathology | - |
dc.subject.keywordPlus | pure red cell anemia | - |
dc.subject.keywordPlus | toxic hepatitis | - |
dc.subject.keywordPlus | Acute Disease | - |
dc.subject.keywordPlus | Cholestasis | - |
dc.subject.keywordPlus | Female | - |
dc.subject.keywordPlus | Hepatitis, Toxic | - |
dc.subject.keywordPlus | Humans | - |
dc.subject.keywordPlus | Liver Function Tests | - |
dc.subject.keywordPlus | Middle Aged | - |
dc.subject.keywordPlus | Platelet Aggregation Inhibitors | - |
dc.subject.keywordPlus | Red-Cell Aplasia, Pure | - |
dc.subject.keywordPlus | Ticlopidine | - |
dc.subject.keywordAuthor | Ticlopidine | - |
dc.subject.keywordAuthor | Pure red cell aplasia | - |
dc.subject.keywordAuthor | Hepatitis | - |
dc.subject.keywordAuthor | Drug-Induced | - |
dc.subject.keywordAuthor | Adverse effect | - |
dc.subject.keywordAuthor | 티클로피딘 | - |
dc.subject.keywordAuthor | 진정적혈구계무형성증 | - |
dc.subject.keywordAuthor | 담즙정체간염 | - |
dc.subject.keywordAuthor | 부작용 | - |
dc.subject.keywordAuthor | Ticlopidine | - |
dc.subject.keywordAuthor | Pure red cell aplasia | - |
dc.subject.keywordAuthor | Hepatitis | - |
dc.subject.keywordAuthor | Drug-Induced | - |
dc.subject.keywordAuthor | Adverse effect | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.